Matches in Nanopublications for { ?s ?p "[Mechanistically, CXCR7-targeting Nanobodies did not inhibit cell cycle progression but instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro, thus acting here as inverse agonists, and subsequent angiogenesis in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Mechanistically, CXCR7-targeting Nanobodies did not inhibit cell cycle progression but instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro, thus acting here as inverse agonists, and subsequent angiogenesis in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP435914.RAhcFT8AsCkjgVJ0BsmqKrFt0f0wkkQkEy-DEvUguI7Ms130_assertion description "[Mechanistically, CXCR7-targeting Nanobodies did not inhibit cell cycle progression but instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro, thus acting here as inverse agonists, and subsequent angiogenesis in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435914.RAhcFT8AsCkjgVJ0BsmqKrFt0f0wkkQkEy-DEvUguI7Ms130_provenance.
- NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_assertion description "[Mechanistically, CXCR7-targeting Nanobodies did not inhibit cell cycle progression but instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro, thus acting here as inverse agonists, and subsequent angiogenesis in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.